Scotts Miracle-Gro Company (The
54.03-1.99 (-3.55%)
Oct 29, 4:00:02 PM EDT · NYSE · SMG · USD
Key Stats
Market Cap
3.12BP/E (TTM)
65.89Basic EPS (TTM)
0.82Dividend Yield
0.05%Recent Filings
8-K
Extends $750M receivables facility
The Scotts Miracle-Gro extended its $750 million receivables facility with JPMorgan Chase Bank through a second amendment signed August 28, 2025, pushing the termination date from September 1, 2025, to September 1, 2026. This uncommitted setup lets subsidiaries sell eligible accounts receivable from five key customers weekly, with the company servicing them for a 20 basis point fee and using proceeds for general corporate needs. Backed by $75 million in standby letters of credit, the facility remains non-recourse except for standard repurchase duties. It secures ongoing liquidity amid receivables management.
10-Q
Q3 FY2025 results
Scotts Miracle-Gro posted solid Q3 FY2025 results, with net sales dipping 1.2% year-over-year to $1.188B amid softer Hawthorne volumes, yet gross margin climbed to 31.8% from 29.5% thanks to lower material costs and better U.S. Consumer mix. Operating income rose 7.4% to $215M, while diluted EPS improved 11.4% to $2.54, reconciling neatly with 58.6 million shares. Cash from operations slowed to $197M year-to-date on inventory builds, but free cash flow held at $142.7M after $54.5M capex; total debt eased to $2.203B with $1.167B revolver availability and leverage at 4.15x, comfortably under covenants. Restructuring costs ticked up to $6.1M, mostly severance. Cannabis oversupply lingers as a drag on Hawthorne.
8-K
Board director retires; general appointed
The Scotts Miracle-Gro Company announced the retirement of Board director Lt. Gen. (ret.) John R. Vines on July 31, 2025, after over 12 years of service on the Nominating & Governance and Innovation & Technology committees; his term was set to end in 2027. The Board appointed Gen. (ret.) Austin Scott Miller to fill the Class II vacancy effective August 1, 2025, assigning him to the same committees. Miller, with extensive military leadership in complex operations, brings strategic expertise to bolster the Board's transformation efforts. This marks the sixth new director since 2022.
8-K
Q3 sales up, margins soar
Scotts Miracle-Gro reported third-quarter fiscal 2025 results on July 30, with U.S. Consumer net sales up 1% to $1.03 billion, driving total sales of $1.19 billion despite a 1% dip. Gross margins surged 230 basis points to 31.8% on better product mix and lower costs, boosting adjusted EBITDA $19.3 million to $256.1 million and EPS $0.28 to $2.59. The company reaffirms full-year guidance, including $570–$590 million adjusted EBITDA, yet Hawthorne sales plunged 54% to $31.2 million.
10-Q
Q2 FY2025 results
Scotts Miracle-Gro posted Q2 FY2025 net sales of $1.42B, down 6.8% y/y from $1.53B, yet gross margin climbed to 38.6% from 30.4% thanks to lower material costs and fewer impairment charges. Operating income rose 26.7% y/y to $345M, while diluted EPS hit $3.72, up from $2.74, reconciling neatly with 58.4M shares. Cash from operations drained $257M amid seasonal inventory builds, offset by $238M in financing inflows; total debt stood at $2.56B with $822M revolver availability and a 4.41x leverage ratio in covenant compliance. Hawthorne sales plunged 50.8% y/y to $33M on cannabis oversupply, but U.S. Consumer held steady with 1.8% segment profit growth. On March 14, 2025, the firm sold its THC subsidiary for a $39M note, retaining a call option for potential reacquisition. Cannabis market volatility lingers as a key risk.
IPO
Website
Employees
Sector
Industry
CENT
Central Garden & Pet Company
31.18-1.24
CTVA
Corteva, Inc.
63.20-0.26
EDBL
Edible Garden AG Incorporated
1.64+0.02
FMC
FMC Corporation
29.04-1.50
GRWG
GrowGeneration Corp.
1.56-0.06
HYFM
Hydrofarm Holdings Group, Inc.
2.44-0.23
MOS
Mosaic Company (The)
28.65-0.73
NMHI
Nature's Miracle Holding Inc.
0.42-0.02
NTR
Nutrien Ltd.
56.44-0.57
SANW
S&W Seed Company
0.22-0.11